Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
298 0 |
SM ISO690:2012 FUIOR, Arcadie, CEBOTARI, Diana, GARBUZ, Olga, CALANCEA, Sergiu, GULYA, Aurelian, FLOQUET, Sebastian. Biological properties of a new class of [Mo2O2S2]-based thiosemicarbazone coordination complexes. In: Inorganica Chimica Acta, 2023, vol. 548, p. 0. ISSN 0020-1693. DOI: https://doi.org/10.1016/j.ica.2022.121372 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Inorganica Chimica Acta | ||||||
Volumul 548 / 2023 / ISSN 0020-1693 | ||||||
|
||||||
DOI:https://doi.org/10.1016/j.ica.2022.121372 | ||||||
Pag. 0-0 | ||||||
|
||||||
Rezumat | ||||||
This paper deals with the biological properties of 14 coordination complexes assembled from a large panel of thiosemicarbazone ligands and [Mo2O2S2]2+ cluster. The investigation of biological properties evidences a high cancer inhibition activity, and antimicrobial, antifungal and antioxidant properties. The complexes based on phenolic ligands are the most active towards tumor cells, while the pyridine derivatives are the most efficient against bacteria and fungi. |
||||||
Cuvinte-cheie antibacterial, antifungal, Antitumoral, molybdenum, thiosemicarbazone |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-172166</cfResPublId> <cfResPublDate>2023-04-01</cfResPublDate> <cfISSN>0020-1693</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/172166</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Biological properties of a new class of [Mo2O2S2]-based thiosemicarbazone coordination complexes</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>antibacterial; antifungal; Antitumoral; molybdenum; thiosemicarbazone</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>This paper deals with the biological properties of 14 coordination complexes assembled from a large panel of thiosemicarbazone ligands and [Mo<sub>2</sub>O<sub>2</sub>S<sub>2</sub>]<sup>2+</sup> cluster. The investigation of biological properties evidences a high cancer inhibition activity, and antimicrobial, antifungal and antioxidant properties. The complexes based on phenolic ligands are the most active towards tumor cells, while the pyridine derivatives are the most efficient against bacteria and fungi.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-50378</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-56410</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-42831</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-14111</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-499</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-51435</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-172166</cfFedIdId> <cfFedId>10.1016/j.ica.2022.121372</cfFedId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-50378</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-50378-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFamilyNames>Fuior</cfFamilyNames> <cfFirstNames>Arcadie</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-56410</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-56410-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFamilyNames>Cebotari</cfFamilyNames> <cfFirstNames>Diana</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-42831</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-42831-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFamilyNames>Garbuz</cfFamilyNames> <cfFirstNames>Olga</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-14111</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-14111-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFamilyNames>Calancea</cfFamilyNames> <cfFirstNames>Sergiu</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-499</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-499-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFamilyNames>Gulya</cfFamilyNames> <cfFirstNames>Aurelian</cfFirstNames> <cfFamilyNames>Гуля</cfFamilyNames> <cfFirstNames>Аурелиан</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-51435</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-51435-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2023-04-01T24:00:00</cfStartDate> <cfFamilyNames>Floquet</cfFamilyNames> <cfFirstNames>Sebastian</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>